Security key
87583X109
Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (TNGX)
CUSIP: 87583X109
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 143,181,938
- Total 13F shares
- 127,196,008
- Share change
- +20,005,984
- Total reported value
- $651,244,300
- Put/Call ratio
- 7.7%
- Price per share
- $5.12
- Number of holders
- 114
- Value change
- +$113,427,538
- Number of buys
- 65
- Number of sells
- 56
Report period
Q2 2025
Institutions
114
Top holders
10
TNGX full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Tango Therapeutics, Inc. SEC filings
Tango Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87583X109
Recent filing periods:
Top shareholders of TNGX - Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TRV GP IV, LLC |
13F
|
Company |
12%
|
16,859,075
|
$23,096,933 | — | 31 Mar 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
7.5%
|
10,736,000
|
$14,708,320 | — | 31 Mar 2025 | |
| EcoR1 Capital, LLC |
3/4/5
13F
|
10%+ Owner · Company |
7.4%
from 13F
|
10,630,736
|
$31,010,920 | — | 06 Nov 2024 | |
| Boxer Capital Management, LLC |
13F
3/4/5
|
Company · Other* |
7.3%
|
10,380,999
|
$14,221,969 | — | 31 Mar 2025 | |
| Nextech Invest, Ltd. |
13F
|
Company |
3.9%
|
5,533,980
|
$7,581,553 | — | 31 Mar 2025 | |
| GILEAD SCIENCES, INC. |
13F
|
Company |
3.4%
|
4,854,443
|
$6,650,587 | — | 31 Mar 2025 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.2%
|
4,610,930
|
$6,316,974 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
2.8%
|
4,032,012
|
$5,523,858 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.7%
|
3,875,545
|
$5,309,497 | — | 31 Mar 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.3%
|
3,312,449
|
$4,539,000 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
2.2%
|
3,219,571
|
$4,410,812 | — | 31 Mar 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
2.1%
|
2,987,983
|
$4,093,537 | — | 31 Mar 2025 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
1.9%
|
2,712,008
|
$3,715,451 | — | 31 Mar 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
1.8%
|
2,565,342
|
$3,514,519 | — | 31 Mar 2025 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
1.5%
|
2,121,652
|
$2,906,663 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.3%
|
1,842,163
|
$2,523,764 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1%
|
1,470,932
|
$2,015,177 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.97%
|
1,383,437
|
$1,895,736 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.8%
|
1,144,443
|
$1,567,887 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.68%
|
973,309
|
$1,327,000 | — | 31 Mar 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.52%
|
737,955
|
$1,010,998 | — | 31 Mar 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.49%
|
708,385
|
$970,487 | — | 31 Mar 2025 | |
| BESSEMER GROUP INC |
13F
|
Company |
0.49%
|
708,384
|
$970,000 | — | 31 Mar 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.46%
|
655,158
|
$963,082 | — | 31 Mar 2025 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.44%
|
630,000
|
$863,100 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.42%
|
605,290
|
$829,863 | — | 31 Mar 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.38%
|
550,000
|
$753,500 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.38%
|
548,014
|
$750,779 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.35%
|
506,188
|
$693,478 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.31%
|
449,382
|
$615,653 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.25%
|
352,897
|
$483,468 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.25%
|
351,489
|
$481,539 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.17%
|
250,519
|
$343,211 | — | 31 Mar 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.17%
|
241,729
|
$331,000 | — | 31 Mar 2025 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.16%
|
232,766
|
$318,889 | — | 31 Mar 2025 | |
| CONGRESS ASSET MANAGEMENT CO |
13F
|
Company |
0.16%
|
227,361
|
$311,485 | — | 31 Mar 2025 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.16%
|
224,077
|
$306,985 | — | 31 Mar 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.15%
|
211,797
|
$290,162 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.14%
|
202,183
|
$276,991 | — | 31 Mar 2025 | |
| TRV GP VI, LLC |
13F
|
Company |
0.14%
|
194,174
|
$266,018 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.12%
|
174,500
|
$239,065 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.12%
|
172,433
|
$236,233 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.12%
|
168,145
|
$230,359 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.11%
|
153,335
|
$210,069 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.1%
|
142,108
|
$194,688 | — | 31 Mar 2025 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.09%
|
129,110
|
$176,881 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
125,000
|
$171,250 | — | 31 Mar 2025 | |
| Casdin Capital, LLC |
13F
|
Company |
0.09%
|
125,000
|
$171,250 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.09%
|
124,865
|
$171,064 | — | 31 Mar 2025 | |
| Graham Capital Management, L.P. |
13F
|
Company |
0.08%
|
116,498
|
$159,602 | — | 31 Mar 2025 |
Institutional Holders of Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (TNGX) as of Q2 2025
As of 30 Jun 2025,
Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (TNGX) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
127,196,008 shares.
The largest 10 holders included
TRV GP IV, LLC, TCG Crossover Management, LLC, EcoR1 Capital, LLC, Boxer Capital Management, LLC, FARALLON CAPITAL MANAGEMENT LLC, Woodline Partners LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Nextech Invest, Ltd., BlackRock, Inc., and GILEAD SCIENCES, INC..
This page lists
113
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
119
Q2 2025 holders
114
Holder diff
-5
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.